Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Transdermal Patch in Alzheimer's Disease
NCT03197740Phase 3Completed
- Sponsor
- Icure Pharmaceutical Inc.
- Start
- Oct 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil transdermal patch in Alzheimer's disease (AD), sponsored by Icure Pharmaceutical Inc.. Started Oct 2017; status: completed.
02
Drugs
donepezil transdermal patch
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03197740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03197740.